Seres Therapeutics, Inc. (MCRB)

NASDAQ: MCRB · IEX Real-Time Price · USD

0.701

-0.021 (-2.91%)

At close: Jul 2, 2024, 4:00 PM

0.737

+0.036 (5.06%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Seres Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2012
Net Income	-113.72	-250.16	-65.58	-89.13	-70.28	Upgrade
Depreciation & Amortization	15.11	11.85	9.22	8.89	9.83	Upgrade
Share-Based Compensation	34.1	25.48	20.22	8.82	8.34	Upgrade
Other Operating Activities	-52.85	-15.99	42.82	-22.2	-24.42	Upgrade
Operating Cash Flow	-117.35	-228.82	6.69	-93.61	-76.52	Upgrade
Capital Expenditures	-7.98	-9.82	-9.57	-0.59	-1	Upgrade
Change in Investments	18.56	92.25	73.65	-158.3	-29.52	Upgrade
Investing Cash Flow	10.58	82.43	64.09	-158.89	-30.52	Upgrade
Share Issuance / Repurchase	21.19	103.9	2.13	303.42	61.66	Upgrade
Debt Issued / Paid	50.52	25.7	-0.95	0	24.58	Upgrade
Financing Cash Flow	71.71	129.6	1.18	303.42	86.23	Upgrade
Exchange Rate Effect	0	-0	-0	0	0	Upgrade
Net Cash Flow	-35.07	-16.79	71.95	50.92	-20.81	Upgrade
Free Cash Flow	-125.33	-238.64	-2.88	-94.2	-77.52	Upgrade
Free Cash Flow Margin	-99.21%	-3347.88%	-1.99%	-283.61%	-224.67%	Upgrade
Free Cash Flow Per Share	-0.98	-2.21	-0.03	-1.18	-1.37	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).